Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial.
Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial.
复制标题
DOI：
10.1038/srep31838
复制
发表时间：
2016
期刊：
影响因子：
--
通讯作者：
Liping Ma
中科院分区：
文献类型：
--
作者：
Pan Li;Ying Gu;Yawei Yang;Lizhi Chen;Junmei Liu;Lihong Gao;Yongwen Qin;Quancai Cai;Xianxian Zhao;Zhuo Wang;Liping Ma
